Fidelity Salem is trading at 9.35 as of the 22nd of July 2025; that is 0.11 percent increase since the beginning of the trading day. The fund's open price was 9.34. Fidelity Salem has about a 20 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 23rd of April 2025 and ending today, the 22nd of July 2025. Click here to learn more.
The fund normally invests at least 80 percent of assets in securities included in the Bloomberg Global Aggregate ex-USD Float Adjusted RIC Diversified Index , which is a multi-currency benchmark that includes fixed-rate treasury, government-related, corporate and securitized bonds from developed and emerging markets issuers while excluding USD denominated debt. More on Fidelity Salem Street
Fidelity Salem Street [FBIIX] is traded in USA and was established 22nd of July 2025. Fidelity Salem is listed under Fidelity Investments category by Fama And French industry classification. The fund is listed under World Bond-USD Hedged category and is part of Fidelity Investments family. This fund currently has accumulated 694.27 M in assets under management (AUM) with no minimum investment requirementsFidelity Salem Street is currently producing year-to-date (YTD) return of 1.42% with the current yeild of 0.0%, while the total return for the last 3 years was 3.37%.
Check Fidelity Salem Probability Of Bankruptcy
Other Information on Investing in Fidelity Mutual Fund
Fidelity Salem financial ratios help investors to determine whether Fidelity Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Fidelity with respect to the benefits of owning Fidelity Salem security.
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance